Skip to main content
. 2020 Jun 16;36:8–14. doi: 10.1016/j.prrv.2020.06.007

Table 1.

Mucus therapies in cystic fibrosis lung disease management.

Therapy Mechanism Form of Administration
Hypertonic Saline Restoration of ASL Height Aerosol mist
Mannitol Restoration of ASL Height Dry-power inhalation
ENaC Inhibitors Restoration of ASL Height N/A
Dornase alfa DNA hydrolysis Aerosol mist
N-acetylcysteine Disulfide bond Aerosol mist